The American Parkinson Disease Association (APDA) has announced three recipients of its inaugural Bridge Funding Awards, a program designed to support promising Parkinson’s disease research when unexpected gaps in funding occur. The awards were open specifically to researchers APDA has funded within the…
News
Researchers creating a map of the developing human brain found that methods used to grow brain cells lost in Parkinson’s disease often inadvertently create other types as well, pointing to the need for more refined modeling. The scientists developed a framework that “provides a foundation for refining protocols toward…
Texas voters a a $3 billion state investment to support research into brain diseases such as Parkinson’s disease, a measure the Michael J. Fox Foundation for Parkinson’s Research (MJFF) called “a decisive step toward transforming the future of brain health and establishing itself as a model for other…
In people with early Parkinson’s disease, buntanetap slowed cognitive decline, with the biggest gains seen in those with mild dementia. Researchers also noted that about a quarter of these patients showed signs of amyloid buildup — a marker linked to Alzheimer’s disease — and…
Annovis Bio has scheduled a January meeting with the U.S. Food and Drug Administration (FDA) to discuss buntanetap as a treatment for dementia due to Parkinson’s disease. The meeting will include discussions about potential clinical trial design, the criteria that will be used to determine which patients…
Researchers have uncovered a previously overlooked type of electrical brain activity — an irregular signal they call noise — that closely tracks the severity of motor symptoms in people with Parkinson’s disease. The discovery, made by scientists at the Max Planck Institute in Germany, in collaboration with research teams…
A $5 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will help Booster Therapeutics develop therapeutics to improve the body’s ability to clear disease-causing proteins that drive Parkinson’s disease. The research grant will support studies into small-molecule therapeutics that activate the proteasome, a cellular…
Frequently eating sweets, red meat, and processed meats appears to increase the risk of developing Parkinson’s disease, while consuming more fruits — especially citrus — may be protective against it, according to a large study from Italy. The researchers found, however, that certain nondietary influences were more strongly…
Alector said it is advancing the development of AL050, an enzyme replacement therapy for Parkinson’s disease, with an eye toward submitting an investigational new drug application to the U.S. Food and Drug Administration (FDA) in 2027. “We are well-resourced to advance our portfolio of innovative drug candidates for…
Photopharmics has completed enrollment of a Phase 3 clinical trial testing Celeste, its light therapy device for Parkinson’s disease, the company announced. The ongoing Phase 3 trial (NCT04453033), dubbed Light for PD, has enrolled 350 participants with Parkinson’s, surpassing the initial target enrollment of 300 patients. Topline results…
Recent Posts
- Deep brain stimulation was a lifesaver for my husband with Parkinson’s
- Me and Mary Jane: My one experience trying marijuana for Parkinson’s
- Low muscle mass is more common in early-stage Parkinson’s disease
- Guest Voice: What de facto parenting can teach us about Parkinson’s
- Parkinson’s advocates urge implementation of new federal plan